For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

CVS Health Corporation CVS is gaining investor attention as the stock trends higher ahead of its second-quarter earnings ...

CVS Health’s CVS stock has gained strong momentum so far in 2025, rising 47.1%. While operating income declined nearly 5% in the fourth quarter of 2024 (as reported last month), impacted by ...

CVS Health CVS and The Cigna Group CI stand as two dominant forces in the U.S. diversified healthcare sector, commanding market capitalizations of approximately $77 billion and $84 billion ...

Shares of CVS are now up more than 45% for the year, unlike the company's main retail pharmacy rival Walgreens, whose stock is up nearly 3%.

Shares of CVS are now up more than 45% for the year, unlike the company's main retail pharmacy rival Walgreens, whose stock is up nearly 3%.

The Ratings Game CVS wins upgrade to buy as analyst sees more upside potential than its peers Leerink boosts CVS to a ‘buy’ as the healthcare-company’s stock stays hot.

Shares of CVS are now up more than 45% for the year, unlike the company's main retail pharmacy rival Walgreens, whose stock is up nearly 3%.

CVS Health executives and hedge fund Glenview Capital Management were reportedly planning to meet today to discuss a shakeup of the pharmacy and health care company's operations.

CVS Health ’s CVS stock has gained strong momentum so far in 2025, rising 47.1%. While operating income declined nearly 5% in the fourth quarter of 2024 (as reported last month), impacted by ...